Cross-presentation of tumour antigens by human induced pluripotent stem cell-derived CD141(+)XCR1+ dendritic cells.
about
Dendritic cells derived from pluripotent stem cells: Potential of large scale productionUnderstanding dendritic cells and their role in cutaneous carcinoma and cancer immunotherapyInduced pluripotent stem cells in hematology: current and future applicationsLow molecular weight hyaluronan-pulsed human dendritic cells showed increased migration capacity and induced resistance to tumor chemoattraction.Interaction of Salmonella typhimurium with dendritic cells derived from pluripotent embryonic stem cells.Induced pluripotent stem cells: challenges and opportunities for cancer immunotherapy.Dendritic cells and pluripotency: unlikely allies in the pursuit of immunotherapy.Harnessing the properties of dendritic cells in the pursuit of immunological tolerance.Dendritic Cell Strategies for Eliciting Mutation-Derived Tumor Antigen Responses in Patients.Inherent Immunogenicity or Lack Thereof of Pluripotent Stem Cells: Implications for Cell Replacement Therapy.Directed Differentiation of Human Induced Pluripotent Stem Cells into Dendritic Cells Displaying Tolerogenic Properties and Resembling the CD141+ Subset.Modelling IRF8 Deficient Human Hematopoiesis and Dendritic Cell Development with Engineered iPS Cells.Cancer Vaccine Therapy Using Carcinoembryonic Antigen - expressing Dendritic Cells generated from Induced Pluripotent Stem Cells.Artificial Antigen Presenting Cells: An Off the Shelf Approach for Generation of Desirable T-Cell Populations for Broad Application of Adoptive Immunotherapy.
P2860
Q26865622-8CED455E-CC7B-466E-AAAE-5BB598E66197Q27004702-FA860184-3FAA-4B27-BD97-39603185E90FQ27016090-DC263F70-8398-4031-B135-BE9D2514A086Q34216061-2A4244E7-0D23-434F-85FD-119DC447033EQ34533395-95B3EE0D-6223-4ACB-85FB-6B0AB30220CCQ38214635-5A757AC6-7CAE-42FA-BF2A-27F6869F5850Q38453644-DB6018B2-EBB8-4DCA-BD4B-D75DF9C3E6E3Q38682156-FB7DA23B-377D-4D6D-880E-E33088A46513Q39243064-A0D897F8-DE2E-4934-92BB-B8BAF7E170B9Q40059574-D36D9B74-35D9-49DD-B2CF-185848CCE08FQ47550123-D0945D98-1630-4F1E-9A19-F431C7741DA3Q51043236-03DB53D7-4355-4BAA-ABCB-C476CEAE3259Q55238759-1963AF92-2658-4DA7-AC3C-F33F8A752473Q55315844-C4F35802-B6F2-492F-8D13-E7CB21322605
P2860
Cross-presentation of tumour antigens by human induced pluripotent stem cell-derived CD141(+)XCR1+ dendritic cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Cross-presentation of tumour a ...... potent stem cell-derived CD141
@nl
Cross-presentation of tumour a ...... CD141(+)XCR1+ dendritic cells.
@en
type
label
Cross-presentation of tumour a ...... potent stem cell-derived CD141
@nl
Cross-presentation of tumour a ...... CD141(+)XCR1+ dendritic cells.
@en
prefLabel
Cross-presentation of tumour a ...... potent stem cell-derived CD141
@nl
Cross-presentation of tumour a ...... CD141(+)XCR1+ dendritic cells.
@en
P2093
P2860
P356
P1433
P1476
Cross-presentation of tumour a ...... CD141(+)XCR1+ dendritic cells.
@en
P2093
A J Leishman
L Carpenter
P J Fairchild
T J Davies
P2860
P2888
P304
P356
10.1038/GT.2011.177
P577
2011-11-10T00:00:00Z
P5875
P6179
1040049242